SINTX Receives Issuance of U.S. Patent for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

Core Insights - SINTX Technologies, Inc. has been granted U.S. Patent No. 12,239,761, enhancing its intellectual property portfolio and solidifying its leadership in silicon nitride innovation [1][2][5] - The patent focuses on advancements in silicon nitride material processing and applications, particularly in the biomedical sector, which is crucial for next-generation implant technology [2][3] - The company is the only FDA-registered producer of implantable silicon nitride, with a diverse portfolio aimed at improving implant longevity and patient safety [4][6] Intellectual Property and Innovation - The newly issued patent covers innovative methods for adhering silicon nitride to various biomaterial substrates, improving biocompatibility and infection resistance [3] - SINTX's intellectual property portfolio now includes 17 issued U.S. patents and 84 pending applications worldwide, reflecting its commitment to innovation [5] Market Position and Applications - SINTX is recognized as a global leader in the research, development, and manufacturing of silicon nitride, with products implanted in humans since 2008 [6] - The company's innovations target orthopedic, craniomaxillofacial, dental, and spinal implants, aligning with its mission to enhance patient outcomes and surgical success rates [3][4]